TD Asset Management
IOVA icon

TD Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$241K Hold
139,878
﹤0.01% 1173
2025
Q1
$466K Sell
139,878
-171,200
-55% -$570K ﹤0.01% 1149
2024
Q4
$2.3M Sell
311,078
-58,200
-16% -$431K ﹤0.01% 970
2024
Q3
$3.55M Buy
369,278
+84,400
+30% +$811K ﹤0.01% 871
2024
Q2
$2.28M Sell
284,878
-220,400
-44% -$1.77M ﹤0.01% 951
2024
Q1
$7.49M Buy
505,278
+247,818
+96% +$3.67M 0.01% 678
2023
Q4
$2.09M Sell
257,460
-78,618
-23% -$639K ﹤0.01% 991
2023
Q3
$1.53M Buy
336,078
+168,522
+101% +$767K ﹤0.01% 1035
2023
Q2
$1.18M Buy
167,556
+50,900
+44% +$358K ﹤0.01% 1091
2023
Q1
$713K Buy
116,656
+2,000
+2% +$12.2K ﹤0.01% 1202
2022
Q4
$733K Sell
114,656
-32,900
-22% -$210K ﹤0.01% 1202
2022
Q3
$1.41M Buy
147,556
+12,300
+9% +$117K ﹤0.01% 1097
2022
Q2
$1.49M Sell
135,256
-25,712
-16% -$284K ﹤0.01% 1090
2022
Q1
$2.68M Buy
160,968
+22,244
+16% +$370K ﹤0.01% 996
2021
Q4
$2.65M Buy
138,724
+7,280
+6% +$139K ﹤0.01% 1067
2021
Q3
$3.24M Hold
131,444
﹤0.01% 946
2021
Q2
$2.93M Sell
131,444
-27,820
-17% -$619K ﹤0.01% 975
2021
Q1
$5.04M Sell
159,264
-36,878
-19% -$1.17M 0.01% 816
2020
Q4
$9.1M Buy
196,142
+23,827
+14% +$1.11M 0.01% 617
2020
Q3
$5.67M Hold
172,315
0.01% 669
2020
Q2
$4.73M Buy
172,315
+15,507
+10% +$426K 0.01% 674
2020
Q1
$4.69M Sell
156,808
-10,800
-6% -$323K 0.01% 634
2019
Q4
$4.64M Sell
167,608
-4,200
-2% -$116K 0.01% 730
2019
Q3
$3.13M Buy
171,808
+6,500
+4% +$118K ﹤0.01% 805
2019
Q2
$4.05M Buy
165,308
+55,800
+51% +$1.37M 0.01% 728
2019
Q1
$1.04M Sell
109,508
-500
-0.5% -$4.75K ﹤0.01% 1032
2018
Q4
$974K Buy
110,008
+7,608
+7% +$67.4K ﹤0.01% 1063
2018
Q3
$1.15M Buy
102,400
+3,600
+4% +$40.5K ﹤0.01% 1127
2018
Q2
$1.27M Buy
98,800
+22,400
+29% +$287K ﹤0.01% 1073
2018
Q1
$1.29M Buy
+76,400
New +$1.29M ﹤0.01% 993
2016
Q4
Sell
-14,931
Closed -$123K 1388
2016
Q3
$123K Buy
+14,931
New +$123K ﹤0.01% 1384